vasculogenesis and arteriogenesis angiopoietins , ephrins...
TRANSCRIPT
Vasculogenesis Vasculogenesis andand ArteriogenesisArteriogenesis
AngiopoietinsAngiopoietins, , ephrinsephrins andand othersothers
lecture VIII
30th April 2012
EC – endothelial cell
P – pericyte
F – fibroblast
VEGF – vascular endothelial
growth factor
PDGF – platelet-derived
growth factor
Ang-1 – angiopoetin-1
Mechanisms of new blood vessels formationMechanisms of new blood vessels formation
Vasculogenesis
EC
P
Endothelial
Progenitor
Cell
Capillary
blood vessel
Angiogenesis
EC
P
EC
EC
P
EC
P
Capillary
blood vessel Network of capillaries
VEGF
Arteriogenesis
EC
P
EC
SMCSMC
SMCSMC
F
F
Primary
blood vesselMature artery
increased blood flow
VEGF + PDGF
VEGF + Ang-1
Vasculogenesis Vasculogenesis
Vasculogenesis begins very early after the initiation of
gastrulation in the mammalian embryo, with the formation
of the blood islands in the yolk sac and angioblast
precursors in the head mesenchyme
capillaries are formed from
vascular progenitor cells
VasculogenesisVasculogenesis
1. First phase
• Initiated from the generation of hemangioblasts;
2. Second phase
• Angioblasts proliferate and differentiate into
endothelial cells
3. Third phase
• Endothelial cells form primary capillary plexus
In the yolk sac, these progenitors aggregate into endothelial-lined blood islands that
then fuse to generate a primary capillary plexus. The primary capillary plexus
undergoes remodelling along with intra-embryonic vessels to form a mature circulation
Hemangioblast is a multipotent cell, common precursor to
hematopoietic and endothelial cells. Hemangioblast was first
hypothesized in 1900 by Wilhelm His.
HemangioblastHemangioblast
Vasculogenesis Vasculogenesis occursoccurs alsoalso inin adultadult organismorganism
Previously, postnatal vascularization was thought to occur exclusively due to
angiogenesis. However, recent investigations have shown that vasculogenesis is
involved in blood vessel formation also during postnatal live and the cells
responsible for that are EPCs.
JCI 1999;103:1231-1236
• Classic Paradigm:
Angiogenesis– Mature ECs migrate and
proliferate to form new vessels
• New Model: Angiogenesis +
Vasculogenesis
– Bone Marrow derived EPCs circulate to sites of neovascularization
MechanismsMechanisms ofof EPCsEPCs hominghoming andand differentiationdifferentiation
Urbich & Dimmeler, Circ Res 2004
Endothelial progenitor cells
A primitive cell made in the bone marrow (or other
organs) that can enter the bloodstream and go to areas
of blood-vessel injury to help repair the damage
IsolectinIsolectin bindingbinding by EPC by EPC
control
isolectin
Lectin from Bandeira simplicifolia
Anna Grochot-Przeczek
ImmunohistochemicalImmunohistochemical characterisationcharacterisation ofof
cultureculture--expandedexpanded EPCsEPCs
Cytoplasmic factor VIII
(von Willebrand factor)
Uptake
of acetylated
low density
lipoproteins
2 weeks
culture
tube formation
on Matrigel
Dzau et al., Hypertension 2005,
MarkersMarkers ofof endothelialendothelial progenitorprogenitor cellscells
CD34
VEGFR2
CD133 (prominin, AC133)
CD133 is absent on mature endothelial cells and monocytic cells
• a powerful mechanism to ensure blood supply to tissue at risk if
a main artery is chronically occluded
• refers to an increase in the diameter of existing arterial vessels
mechanical stimulation chemical stimulation
elevated blood pressure and
increased blood flow
upregulation of cytokines
and cell adhesion receptors
VEGF, MCP-1, TNF-α, bFGF,
MMP, angiopoietins,
fluid shear stress is induced
by the altered blood flow conditions
after an arterial occlusion –
shear stress is a force of the flowing blood on the
endothelial surface of the blood vessel
ArteriogenesisArteriogenesis
DifferencesDifferences BetweenBetween
AngiogenesisAngiogenesis andand ArteriogenesisArteriogenesis
AbleUnableCompensation for
an occluded artery
10- to 20-fold1.5- to 1.7-foldIncreases blood flow
maximally
Inflammation because of
increased shear stress
Inflammation because of
ischemic focal tissue damage
Cellular mechanism
Shear stressIschemiaTrigger
Pre-existing arteriolesPre-existing capillariesSource
Growth of collateral
arteries
Formation of new capillaries
by sprouting
Definition
ArteriogenesisAngiogenesis
ArteriogenesisArteriogenesis -- collateralcollateral circulationcirculation
This is a process in which small (normally closed)
arteries open up and connect two larger arteries or
different parts of the same artery.
They can serve as alternate routes of blood supply.
Collateral vessels (arteriogenesis) can develop
around the site of coronary occlusion
(a) remodelling of pre-existing
vessels that gradually
enlarge to the point at which
they can carry the bulk of
blood flow
budding of new vessels from
post-capillary venules on the
adventitial surface of the
occluded artery that
gradually expand and
connect to the distal arterial
segment.
Growth of collateral blood vessels (arteriogenesis) is potentially
able to preserve structure and function of organs after
occlusion of a major artery.
The remodeling process depends on the following conditions:
(1) existence of an arteriolar network that connects the preocclusive with
the postocclusive microcirculation;
(2) activation of the arteriolar endothelium by elevated fluid shear stress;
(3) invasion (but not incorporation) of bone marrow–derived cells
(4) proliferation of endothelial and smooth muscle cells.
1. The initial triggers of arteriogenesis are physical forces like
fluid shear stress
2. Attraction and invasion of circulating blood cells – monocytes
3. Proliferation of vascular wall cells
4. Remodeling processes with digestion and rearrangement of
the extracellular matrix and elastic lamina.
ArteriogenesisArteriogenesis –– stepssteps
Waltenberger 2001, Circulation
ArteriogenesisArteriogenesis inin collateralcollateral developmentdevelopment –– involvementinvolvement ofof
endothelialendothelial cellscells, , smoothsmooth musclemuscle cellscells andand monocytesmonocytes
ArteriogenesisArteriogenesis –– stepssteps
This series of electron microscopic figures shows subsequent steps of
the collateral vessel wall invasion by blood monocytes
HeilHeil, , SchaperSchaper CircCirc ResRes 20042004
Monocytes in collateral artery growth
Role Role ofof VEGFRVEGFR--1 1 inin arteriogenesisarteriogenesis ––
stimulationstimulation ofof monocytemonocyte migrationmigration
Waltenberger 2001, Circulation
PlGF
Integrins E, P selectin VEGFR-1 VEGFR-2 TIE-2 TIE-1
sVEGFR NRP-1 VEGFR-3
ephrins
IgG superfamily
(VCAM-1, ICAM-1)
Ang1
Ang2
Ang3
Ang4
B1 A1 B2
B2 B3 B4 A2
ephrin receptors
A B C D E PlGF
VEGF
?
+
-
-
+
DiversityDiversity ofof angiogenic angiogenic factorsfactors//receptorsreceptors
Jain and Munn Nature Med. 2000, modified
TwoTwo classesclasses ofof endothelialendothelial cellcell specificspecific tyrosinetyrosine kinasekinase receptorsreceptors
Jones N et al., Jones N et al., NatureNature CellCell BiolBiol 20012001
Ig-like domain
EGF-like
cysteine repeats
Fibronectin type III
homology domains
Tyrosine kinase domain
TieTie--1 1 andand TieTie--2 2 receptorsreceptors
1. Endothelial cell specific tyrosine kinase receptors
2. Built of extracellular and intracellular domains – different than
VEGF receptors
3. Expressed early in development, especially in endothelial cells
4. Tie-1/Tie-2 – specific markers of EC, are also present on
certain hematopoietic cell types
5. Tie –2 - receptor for angiopoietins
Tie –1 - ?
KnockoutsKnockouts ofof TieTie--1 1 andand TieTie--2 2 receptorsreceptors
Tie-1 -/- die between E13.5 and E18.5
normal development up to E13.0; then local hemorrhage,
edema, rupture of microvessels
Tie-2 -/- die at E10.5
cardiac failure, hemorrhage, other vascular defects
embryos have low number of endothelial cells, lack of smooth
muscle cells
69% 63%
AngAng--11
AngAng--22
coiled-coil domain fibrinogen-like domain
responsible for
oligolimerization pattern
mediates
receptor phosphorylation
C
C
N
N
44%
42% 55%
57% AngAng--33
AngAng--44C
C
N
N
AngiopoietinsAngiopoietins
AngAng--1 1
1. Ligand for Tie-2
2. Does not induce endothelial cell proliferation, but is required
for their survival
3. Expressed in the myocardium and perivascular cells
4. Ang-1-/- - defects similar to Tie-2-/-
- death of embryos at E12.5,
- lack of stabilization and remodelling of vessels – lack of the
interaction between endothelial and supporting cells
AngAng--1 1 activitiesactivities
• is responsible for sprouting angiogenesis (like VEGF) but Ang-1 is a weak
mitogen for endothelial cells
• gene knockout studies have demonstrated that VEGF is necessary for the
formation of the initial vascular plexus during embryogenesis, whereas Ang-1 is
essential for subsequent remodeling, maturation and stabilization of vessels
• the mechanism of Ang-1 on migration, tube formation and
survival of endothelial cells in vitro is mediated via PI3K and
downstream effectors of the cascade
• overexpression of Ang-1 leads to strong vasculature, probably
due to the promotion of remodeling and inhibition of pruning
AngAng--1 1 activitiesactivities
Central role Central role ofof Akt Akt kinasekinase inin angiogenesisangiogenesis signalingsignaling
Dimmeler & Zeiher, Circ Res 2000
Overexpression of Ang-1 in the
skin of transgenic mice
IncreasedIncreased Vascularization in Vascularization in MiceMice
OverexpressingOverexpressing AngiopoietinAngiopoietin--1 1
Suri et al, Science 1998
skin phenotype
in newborn
Skin phenotype in adult Ang1 transgenic mice –
big differences
IncreasedIncreased Vascularization in Vascularization in MiceMice
OverexpressingOverexpressing AngiopoietinAngiopoietin--1 1
Suri et al, Science 1998
Ang-1 exerts effects which areopposite to VEGF action
• in contrast to VEGF, which is one of the strongest vascular permeability factor, Ang-1 decreases vessels permeability. In this way Ang-1 can protect blood vessels from the VEGF activity and connected tissue edemas
• Ang-1 overexpression may have also an anti-inflammatory effect. VEGF stimulates endothelium to produce tissue factor and induces inter-cellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1(VCAM-1) and E-selectin expression which leads to the adhesion of leukocytes. Ang-1 may protect from these harmful effects of VEGF.
Ang-1 has anti-permeability &
anti-inflammatory functions
VEGF
vascular permeability factor (VPF)
VCAM-1 ICAM-1 E-selectin
adhesion of leukocytes
Thurston et al., Nature Med. 2000
StrongStrong VEGF VEGF expressionexpression inducesinduces massivemassive edemaedema ––
VEGF VEGF isis alsoalso a a vascularvascular permeabilitypermeability factorfactor
massive edema in four organs
36 h after intravenous
administration of AdVEGF
Thurston et al., Science 1999
Comparison of untreated ear skin of wild-type, K14-VEGF and K14-Ang1 mice
The skin of K14-VEGF
mice was redder than
normal, but, unlike the
skin of K14-Ang1 mice, it
was also thicker than
normal, with regions of
increased cellularity and
foci of inflammatory cells.
Leakage-resistant blood vessels
in mice overexpressing Ang-1
Thurston et al., Science 1999
increase in
vessel length
increase in
vessel diameter
LeakageLeakage--resistantresistant bloodblood vesselsvessels inin mice mice overexpressingoverexpressing AngAng--11
Thurston et al., Science 1999
ComparisonComparison ofof plasmaplasma leakageleakage inin earear skinskin
afterafter treatmenttreatment withwith inflammatoryinflammatory agentsagents
mustard oil - an inflammatory
agent that induces plasma
leakage and inflammation
in the skin
Evans blue dye to
visualize leakage
Thurston et al., Nature Med. 2000
SystemicSystemic AngAng--1 1 productionproduction by by adenoviraladenoviral genegene
deliverydelivery causescauses resistanceresistance to to vascularvascular leakageleakage
Ears of mice treated with
Ad–Ang1 or Ad–GFP and,
3 d later, injected
intravenously with Evans
blue dye to visualize
plasma leakage, followed
by exposure to saline or
mustard oil for 30 min.
• viral overexpression of Ang-1 increases lymphangiogenesis in
mouse skin and cornea
• influence of Ang-1 on lymphangiogenesis is connected with
upregulation of VEGFR-3
Thus, similarly to Ang-1 and VEGF cooperation in blood vessel
development, crosstalk with VEGF-C and D during formation of
lymph vessels can occur
AngAng--1 1 inin lymphangiogenesislymphangiogenesis
Formation of filopodia and
endothelial sprouts was observed
already 2 days after adenoviral
delivery of Ang1 and VEGF-C
At 4 days, the sprouting and
endothelial activation increased
in the Ang1-treated and VEGF-C
ears
After 14 days, both Ang1- and
VEGF-C–treated samples showed
vessel network formation and
stabilization of the lymphatic
endothelium
AngiopoietinAngiopoietin--1 1 promotespromotes lymphaticlymphatic
sproutingsprouting andand hyperplasiahyperplasia
Tammela et al.. Blood 2005
AngiopoietinAngiopoietin--22
1. Ligand for Tie-2 - antagonist of Ang-1 in some cells
- but in others – can phosphorylate Tie-2
2. Expressed at low level by endothelial cells, but is strongly
upregulated at sites of active vascular remodeling - ovary,
tumors
3. Is upregulated at times of both vessel growth and regression
– thus Ang-2 plays an active role in blood vessel remodeling
4. Ang-2 -/- - born relatively normal, but many die at 14 day –
defects in remodeling of the vessels
5. Transgenic overexpression of Ang-2 disrupts blood vessel
formation
Ang-2-deficient mice are born apparently normal - the functionally
unaffected blood vascular system of Ang-2-deficient mice has only
minor abnormalities
In contrast to the mild phenotype of Ang-2-deficient mice, mice
transgenically overexpressing Ang-2 have an embryonic lethal
phenotype that essentially phenocopies the Ang-1-null and Tie-2-
null phenotypes
The similarity of the Ang-1 loss-of-function phenotype with the Ang-2 gain-of-
function phenotype strongly supports the antagonistic concept of Ang-1 and Ang-2
functions
AngiopoietinAngiopoietin--22
• Ang-2 is an antagonist of Tie-2 receptor- it binds to Tie-2 without inducing signal transduction in Tie-2-expressing
endothelial cells
- it antagonizes the binding of Ang-1 to the Tie-2 receptor
• its action is dependent on the VEGF expression
high VEGF level
Ang-2 cooperates with VEGF
enhancement of
angiogenesis
absence of VEGF
blood vessels remodeling
Ang-2 is upregulated in sites of
vessels regression
AngAng--2 2 andand VEGFVEGF
TieTie--2 ligand Angiopoietin2 ligand Angiopoietin--2 2
destabilizesdestabilizes quiescentquiescent endotheliumendothelium
HUVECs - human umbilical-vein endothelial cells
HUASMCs - human umbilical artery smooth-muscle cells
A-422885.66 - the low-molecular-weight Tie-2 inhibitor
Three dimensional co-culture model of endothelial cells and smooth-muscle
cells was used. In this model, smooth-muscle cells form the core of a spheroid
that is covered by a monolayer of endothelial cells. The surface endothelial
monolayer can be visualized by whole-mount CD31 or ICAM-1
immunocytochemistry
Scharpfenecker M et al. J Cell Sci 2005
Scharpfenecker, M. et al. J Cell Sci 2005
Induction of endothelialInduction of endothelial--cell detachment from endothelialcell detachment from endothelial--cell/smoothcell/smooth--
musclemuscle--cell cocell co--culture spheroids by pharmacological Tieculture spheroids by pharmacological Tie--2 inhibition2 inhibition
Scharpfenecker, M. et al. J Cell Sci 2005
Time course of AngTime course of Ang--22--mediated endothelialmediated endothelial--cellcell--monolayer monolayer
destabilization in HUVEC/HUASMC codestabilization in HUVEC/HUASMC co--culture spheroidsculture spheroids
Early development Late development & Adult
VEGF endothelial cells Ang1 vessel maturation
differentiation (agonist) & stabilization
proliferation
tube formation
Ang2(antagonist)
vessel de-stabilization
+ VEGF No VEGF
Adult neovascularization Vessel regression
AngAng--3 3 andand AngAng--44
• they bind to Tie2 receptor
• in experiments with human endothelial
cell lines, Ang3 was identified as an
antagonist of Tie2 and Ang4 was found to be
an agonist of Tie2
Ang4, but not Ang3, strongly induces Tie2 and
Akt phosphorylations in HUVECs
Lee et al., FASEB Journal
mouse Ang3 and human Ang4 were used
Ang3 is more potent than Ang4 in Akt phosphorylation and
survival in primary cultured mouse ECs
Both Ang3 and Ang4 induce strong angiogenesis in vivo
angiogenesis in the mouse corneal micropocket assay
Lee et al., FASEB Journal
Model for the action of Ang3 and Ang4 in human Tie2 and mouse Tie2. Ang4 is a
relatively potent agonist whereas Ang3 is a very weak agonist to human Tie2.
In comparison, Ang3 is a relatively potent agonist whereas Ang4
is a moderate agonist to mouse Tie2.
Lee et al., FASEB Journal
Integrins E, P selectin VEGFR-1 VEGFR-2 TIE-2 TIE-1
sVEGFR NRP-1 VEGFR-3
ephrins
IgG superfamily
(VCAM-1, ICAM-1)
Ang1
Ang2
Ang3
Ang4
B1 A1 B2
B2 B3 B4 A2
ephrin receptors
A B C D E PlGF
VEGF
?
+
-
-
+
DiversityDiversity ofof angiogenic angiogenic factorsfactors//receptorsreceptors
Jain and Munn Nature Med. 2000, modified
EphrinsEphrins andand EphEph receptorsreceptors
Eph receptor tyrosine kinase family and their ligands,
ephrins, are critical regulators of vascular remodeling during
embryogenesis and in tumor neovascularization
• ephrins (Eph family receptor interacting proteins)
• the Eph receptors family (Erythropoietin-producing human
hepatocellular carcinoma) is the largest known family of receptor
tyrosine kinases consisting of 16 members
• both Eph receptors and their ligands are divided in two
subfamily – A and B
• ligands of EphrinA class are glycosylphosphatidylinisotol (GPI)-
anchored peripheral membrane molecules, whereas ephrinB
subfamily is formed by transmembrane proteins with cytoplasmic
domain
EphrinEphrin receptorsreceptors andand ephrinephrin ligandsligands
Augustin & Reiss, Cell Tissue Res, 2003
Eph receptors are present in high degrees during vasculogenesis
and early development of the circulatory system
They play a role in
- distinguishing between arterial and venous endothelium
- stimulation of the production of capillary sprouts
- differentiation of mesenchyme into perivascular support cells
Role Role ofof ephrinephrin//EphEph receptorsreceptors inin angiogenesisangiogenesis
Ephrin B2 – an early marker of arterial endothelial cells
EphB4 – marks venous endothelial cells
EphrinsEphrins andand EphEph receptorsreceptors ––
markersmarkers ofof arterioarterio--venousvenous identityidentity
EphrinB2 -/- - lethal at E10.5
Significant defects in vessels remodeling and sprouting
EphB4 -/- – also die at E10.5
BloodBlood vesselvessel defectsdefects inin ephrinB2 ephrinB2
nullnull mutant mutant embryosembryos andand yolkyolk sacssacs
growth retardation in ephrinB2
null mutant embryos
the normal formation of blood islands and
primary capillary plexus in wild-type, but
failure of angiogenic remodelling into larger
vessels in the mutant yolk sac
Mesoderm formation
Vascular DevelopmentVascular Development
Karkkarnin et al., 2002 Nature Cell Biology
Vasculogenesis
Lymphangiogenesis
Angiogenesis
Hemangioblasts
Blood island formation
Endothelial cells
Hematopoietic
cells
Primary vascular
plexus
Lymphatics
Lymphangioblasts
Capillaries
VE-Cadherin
bFGF
VEGF A
VEGFR-1/2/3
TGFb
EphrinB2/EphB4
Endoglin Notch
Ang1/2
Tie2
PDGF B
Id1/3
VEGF C/D
VEGFR-3
VEGF A
VEGFR-2
TGFb
Notch on Notch off
Notch is a large transmembrane receptor that is important for normal neurogenesis, somite
formation and lymphoid cell development. It plays a special role in blood vessel development.
CrossCross--talk talk betweenbetween ephrinBephrinB--EphB4 EphB4 andand VEGF/Ang1VEGF/Ang1
VEGF Ang1
PI3K kinase
Akt
EC survival
MAPK
EC proliferation
EphrinEphrin B2B2
Arterial EC
Evidence for Importance of Notch in Evidence for Importance of Notch in
Regulating Vascular FormationRegulating Vascular Formation
Notch -/- mouse embryo: primary plexus is
formed but there is lack of large and small vessels
Ephrins/Eph in tumors
• Overexpression of Eph receptors has been detected in different
types of solid tumors
• First evidence come from 1987 when EphA1 was found to be
more than 10-fold overexpressed in human hepatocellular
carcinoma cell line
• EphA1 was found to be expressed also in liver, lung, breast and
colon carcinoma
• EphA2 is upregulated in ovarian, lung, liver, gastrointestinal,
prostate cancers as well as melanomas and glioblastoma
• The expression of other members of the Eph receptors and also
ephrins is increased in a number of cancers and tumor cell lines
Integrins E, P selectin VEGFR-1 VEGFR-2 TIE-2 TIE-1
sVEGFR NRP-1 VEGFR-3
ephrins
IgG superfamily
(VCAM-1, ICAM-1)
Ang1
Ang2
Ang3
Ang4
B1 A1 B2
B2 B3 B4 A2
ephrin receptors
A B C D E PlGF
VEGF
?
+
-
-
+
DiversityDiversity ofof angiogenic angiogenic factorsfactors//receptorsreceptors
Jain and Munn Nature Med. 2000, modified
VE-cadherin
• Vascular Endothelial-cadherin (VE-cadherin) is a calcium-
dependent cell-cell adhesion glycoprotein built of five
extracellular cadherin repeats, a transmembrane region and a
highly conserved cytoplasmic tail
• VE-cadherin interacts with α-, β- and γ-catenin
• VE-cadherin can signal with VEGFR-2 to mediate PI3K/Akt-
dependent endothelial cell survival
Role Role ofof VEVE--cadherincadherin inin angiogenesisangiogenesis
VEVE--cadherincadherin isis indispensableindispensable for for
properproper vascularvascular developmentdevelopment
Gory-Fauré et al. Development 1999
mutant embryogrowth retardation, anemia,
pericardial hypertrophy and
incomplete folding.
External appearance of E10.5 yolk sacs. Blood
islands of the homozygous mutants remained
isolated (B,D), as opposed to the organized
vasculature of the wild type (A,C).
Role Role ofof VEVE--cadherincadherin inin angiogenesisangiogenesis
Disruption of VE-cadherin impairs angiogenesis – knockouts die at E9.5
Deficiency of VE-cadherin blocked the capacity of endothelial cells to respond to
survival signals induced by VEGF-A, by preventing formation of a complex
consisting of VE-cadherin, β-catenin, PI3-K, and VEGF receptor-2 (VEGFR-2)
Carmeliet et al., Cell 1999
AKT
survival
VE-cadherin VEGF-A
VEGFR2
PI3-Kβ-cat
Integrins E, P selectin VEGFR-1 VEGFR-2 TIE-2 TIE-1
sVEGFR NRP-1 VEGFR-3
ephrins
IgG superfamily
(VCAM-1, ICAM-1)
Ang1
Ang2
Ang3
Ang4
B1 A1 B2
B2 B3 B4 A2
ephrin receptors
A B C D E PlGF
VEGF
?
+
-
-
+
DiversityDiversity ofof angiogenic angiogenic factorsfactors//receptorsreceptors
Jain and Munn Nature Med. 2000, modified
VascularVascular integrinsintegrins
A large number of vascular cell surface glycoproteins that function as
cell adhesion receptors to extracellular matrix and in cell-cell adhesion
• Vitaxin is in Phase II trial for colorectal cancer
• a humanized version of the antiangiogenic antibody LM609 directed against a
conformational epitope of the αvβ3 integrin complex
Vitaxin
• a promising angiogenesis inhibitor used in the treatment of some forms of
cancer
Abegrin
• Abegrin is a monoclonal antibody to human integrin αVβ3, a cell adhesion
molecule highly expressed on actively angiogenic endothelium and glioblastoma
multiforme tumor cells
AntiAnti--angiogenicangiogenic factorsfactors directeddirected againstagainst integrinsintegrins
Mice harboring either M21 (A) or A375 (B) melanoma xenografts were treated with 10
mg/kg Abegrin™ delivered thrice weekly starting on day 1 following tumor implantation.
M21 A375
Mulgrev, Mol Cancer Ther. 2006
AbegrinAbegrin™™ inhibitsinhibits humanhuman melanoma melanoma
tumor tumor cellcell growthgrowth inin vivovivo
TakeTake homehome messagesmessages
• Arteriogenesis is the third way of blood vessels formation
stimulated by elevated shear stress
• Ang1 and Ang2 act via Tie-2 receptor, but Ang-1 is an agonist
whereas Ang-2 antagonist of the receptor
• Ang-1 protects from increased permeability
• Ephrin/Eph receptors are markers of arterio-venous identity
• Adhesion molecules (VE-cadherin, integrins) play important
role in angiogenesis